ClinicalTrials.Veeva

Menu
R

Retina Consultants of Charleston | Retina Research of Beaufort

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

KSI-301
Aflibercept
Avacincaptad pegol
OCS-01
Zimura
ANX007
dexamethasone

Parent organization

This site is a part of Retina Consultants of Charleston

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 8 total trials

A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA) (ARCHER II)

The primary purpose of the study is to determine if IVT injections of vonaprument every month reduce vision loss in participants with dry AMD with GA.

Active, not recruiting
Geographic Atrophy
Drug: Vonaprument
Other: Sham Administration

ABBV-RGX-314 (also known as RGX-314 and surabgene lomparvovec (sura-vec)) is being developed as a novel one-time gene therapy for the treatment of ne...

Enrolling
Wet Age-related Macular Degeneration
WetAMD
Genetic: ABBV-RGX-314 Dose 1
Biological: Aflibercept (EYLEA®)

Trial sponsors

Kodiak Sciences logo
AbbVie logo
A
Astellas logo
I
O

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems